FLC
CERE

Fifth Lane Capital’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Fifth Lane Capital’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,500
Closed -$307K – 128
2024
Q2 		$307K Buy
+7,500
New +$312K 0.44% 32

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return